Table 4.
Most commonly occurring drug interactions in hypertensive chronic kidney disease patients
| Interacting pair | Frequency | Percentage |
|---|---|---|
| Ferrous sulfate + omeprazole | 27 | 5.8 |
| Calcium/vitamin D + ciprofloxacin | 21 | 4.5 |
| Captopril + furosemide | 21 | 4.5 |
| Calcium gluconate + ceftriaxone sodium | 16 | 3.4 |
| Calcium gluconate + ferrous sulfate | 14 | 3.0 |
| Ciprofloxacin + ferrous sulfate | 14 | 3.0 |
| Amlodipine + atenolol | 13 | 2.8 |
| Atenolol + prazosin | 10 | 2.2 |
| Amlodipine + prednisolone | 9 | 1.9 |
| Amlodipine + ciprofloxacin | 8 | 1.7 |
| Aspirin + calcium/vitamin D | 8 | 1.7 |
| Ciprofloxacin + metronidazole | 7 | 1.5 |
| Furosemide + lisinopril | 7 | 1.5 |
| Amlodipine + aspirin | 6 | 1.3 |
| Amlodipine + carbamazepine | 6 | 1.3 |
| Aspirin + sodium bicarbonate | 6 | 1.3 |
| Aspirin + insulin human regular | 5 | 1.1 |
| Ciprofloxacin + prednisolone | 5 | 1.1 |
| Amlodipine + simvastatin | 4 | 0.9 |
| Atorvastatin + clopidogrel | 4 | 0.9 |
| Carbamazepine + ciprofloxacin | 4 | 0.9 |
| Carbamazepine + omeprazole | 4 | 0.9 |
Notes: The frequency and percentage depicted in the table is based on total 465 interactions that were observed in hypertensive chronic kidney disease patients.